ANDA 83604, held by Ivax Sub Teva Pharms. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 83604 (Promethazine Hydrochloride), held by Ivax Sub Teva Pharms, was first approved by FDA on Sep 17, 1973, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 17, 1973 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride12.5MG ยท tablet;oral | Promethazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters